Matthew Norkunas - 15 Oct 2023 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Benjamin Waters, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
15 Oct 2023
Net transactions value
-$8,667
Form type
4
Filing time
17 Oct 2023, 18:00:17 UTC
Previous filing
18 Jul 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +7,437 +22% 40,933 15 Oct 2023 Direct F1
transaction GBIO Common Stock Tax liability $7,073 -2,183 -5.3% $3.24 38,750 15 Oct 2023 Direct
transaction GBIO Common Stock Options Exercise +1,674 +4.3% 40,424 15 Oct 2023 Direct F1
transaction GBIO Common Stock Tax liability $1,594 -492 -1.2% $3.24 39,932 15 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -7,437 -50% $0.000000 7,437 15 Oct 2023 Common Stock 7,437 Direct F1, F2
transaction GBIO Restricted Stock Units Options Exercise $0 -1,674 -17% $0.000000 8,366 15 Oct 2023 Common Stock 1,674 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
F3 On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter.